The damage is irreversible
Both medications belong to the GLP-1 receptor agonist class and work by affecting the digestive system in similar ways
While not everyone taking these medications will experience dental problems, the number of reports has grown significant enough that dentists across the countryincluding here in Baton Rougeare taking notice and urging patients to be proactive about their oral care
Semaglutide is a clinically proven GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a naturally occurring hormone in the body responsible for regulating insulin secretion, glucose metabolism, and appetite
Additionally, individuals dealing with insulin resistance or prediabetes often respond exceptionally well once the medication helps stabilize their blood sugar
Estimates suggest that around 5% of people in the United States have MASH, and around a third have an earlier stage, metabolic dysfunction-associated steatotic liver disease (MASLD)